Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant binding » significant burden (Expand Search), significant benefits (Expand Search)
binding decrease » binding database (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant binding » significant burden (Expand Search), significant benefits (Expand Search)
binding decrease » binding database (Expand Search)
-
2301
Downregulation of miR-1247-3p inhibited apoptosis and reduced chemosensitivity in cells.
Published 2024Subjects: -
2302
-
2303
-
2304
Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer
Published 2024“…Among them, <b>E35</b> demonstrated excellent inhibitory activities against the binding of Skp2–Cks1. In addition, compound <b>E35</b> significantly inhibited colony formation and migration, as well as arrested the cell cycle at the S-phase. …”
-
2305
Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer
Published 2024“…Among them, <b>E35</b> demonstrated excellent inhibitory activities against the binding of Skp2–Cks1. In addition, compound <b>E35</b> significantly inhibited colony formation and migration, as well as arrested the cell cycle at the S-phase. …”
-
2306
Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer
Published 2024“…Among them, <b>E35</b> demonstrated excellent inhibitory activities against the binding of Skp2–Cks1. In addition, compound <b>E35</b> significantly inhibited colony formation and migration, as well as arrested the cell cycle at the S-phase. …”
-
2307
Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer
Published 2024“…Among them, <b>E35</b> demonstrated excellent inhibitory activities against the binding of Skp2–Cks1. In addition, compound <b>E35</b> significantly inhibited colony formation and migration, as well as arrested the cell cycle at the S-phase. …”
-
2308
Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer
Published 2024“…Among them, <b>E35</b> demonstrated excellent inhibitory activities against the binding of Skp2–Cks1. In addition, compound <b>E35</b> significantly inhibited colony formation and migration, as well as arrested the cell cycle at the S-phase. …”
-
2309
-
2310
-
2311
-
2312
-
2313
-
2314
-
2315
-
2316
-
2317
-
2318
-
2319
-
2320